Home
About
Overview
Sharing Data
ORCID
Help
History (9)
O-001 A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohn's Disease Refractory to Anti-TFNa: UNITI-1.
Closing the Cervical Cancer Screening Gap-Reaching Sexual and Gender Diverse Populations.
Principal Investigator
Principal Investigator
Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma.
Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma. Leukemia. 2025 Sep; 39(9):2285-2288.
View in:
PubMed
authors with profiles
Michael Drazer
Jennifer Cooperrider
Caner Saygin
Andrzej Jakubowiak
Benjamin Derman